U.K. Controlled trial of intrapleural streptokinase for pleural infection.
about
Management of pleural effusion, empyema, and lung abscessIntra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyemaA polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patientsWhen size matters: changing opinion in the management of pleural space-the rise of small-bore pleural cathetersYear in review 2014: Lung cancer, pleural diseases, respiratory infections and tuberculosis, bronchoscopic intervention and imagingRole of interventional pulmonology in the management of complicated parapneumonic pleural effusions and empyemaChest drainageIntrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infectionPneumonia and empyema: causal, casual or unknownPleural procedural complications: prevention and managementMicrobiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in KoreaThe time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions--analysis of predictors for failure of therapy and bleeding: a cohort study.Mannose-binding lectin genotypes: lack of association with susceptibility to thoracic empyema.Costs of treating children with complicated pneumonia: a comparison of primary video-assisted thoracoscopic surgery and chest tube placement.Pleural infection and empyema.The use of thrombolytics in the management of complex pleural fluid collectionsThe bacteriology of pleural infection by genetic and standard methods and its mortality significance.Blood Culture Bottle and Standard Culture Bottle Methods for Detection of Bacterial Pathogens in Parapneumonic Pleural Effusion.Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre.Factors predictive of the failure of medical treatment in patients with pleural infection.Host cytokine responses distinguish invasive from airway isolates of the Streptococcus milleri/anginosis group.Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema.Two sequential tPA/DNase courses for noncommunicating loculated collections in pleural infectionAbility of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settingsClinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusionsIkappaB genetic polymorphisms and invasive pneumococcal disease.Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhoodAssessment of the usefulness of video-assisted thoracoscopic surgery in patients with non-tuberculous thoracic empyema.Association of asthma and hay fever with irregular menstruation.Effects of extracellular DNA on plasminogen activation and fibrinolysis.A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits.Does videothoracoscopy improve clinical outcomes when implemented as part of a pleural empyema treatment algorithm?Pleural infection-current diagnosis and management.Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae.Intrathoracic irrigation with arbekacin for methicillin-resistant Staphylococcus aureus empyema following lung resection.Pneumonia in the immunocompetent patientTube thoracostomy: how to insert a chest drain.
P2860
Q22250926-7724060D-CA84-4912-8732-DAF72C4E6364Q24243147-DE59F7F5-D003-43CC-A6DA-7093B502337FQ24652357-0AB53919-57C6-4D1E-82E7-8B54B4864467Q26738595-7C92566A-A4AF-4A77-8726-3C93B1A1346BQ26829302-38B644B0-2326-4270-B545-CBE915BDC35CQ26851796-9C720C85-40D6-4941-9BC2-2F520B18113EQ26861427-30328464-50AD-4676-8C61-3A2DFA7B5504Q28082543-5AF0B349-A90B-4545-980B-7F3695DD9598Q28082965-25D8E714-CBE5-4CC3-A2D9-E2F90B3FC186Q28083331-1192B68A-3F6F-4F84-815C-8304AA93916DQ28553554-B36273D8-E2F0-479B-815E-64AF90A8FD4CQ30374418-D42A075C-2845-4DF7-98E1-B176F92CA2D0Q30532487-1B1F6011-8566-4A15-8F6B-4A0AC7EA4981Q30537008-D0037431-AD71-4CBD-9E22-F156A8A6F835Q33524565-E87505F7-463B-4C31-BD2B-AEC3F9B114EDQ33556037-8569F681-E15F-4EA0-8CE2-68AD733D1C6AQ33612343-1B4F5783-3C34-478B-9A8B-2ABA24631725Q33780221-A6BFA1E7-A847-48C2-81AC-5D40A303DD36Q33997631-C1424845-E499-4AF3-BAFB-6FE8BA97A80DQ34045443-70C9CEF1-6E10-4254-A1AD-8103F6416FCCQ34140338-254CB950-AF25-4172-9D3B-699DEF29EAE2Q34184601-DFDED282-0961-4CA9-9431-15FC8E2EFAE4Q34246158-96C1D9B6-5D9D-4828-9C00-E5877B60A256Q34284578-12442314-F3B3-4FE8-B5B5-BEAE7BD8D5F3Q34286292-41DFD60A-8ABB-4C7F-90C4-2F47261F2CE9Q34515699-7AB8126B-C89C-4644-A21C-6A95DAE629CEQ34544728-9A0A1691-5F2B-4855-B7F8-9FE578E7EF37Q34623450-4188B565-2DAF-46B0-ACA8-320724147A94Q35038706-330311FB-68AE-4B82-A05F-0FAEC5F01489Q35290738-409F46BC-098F-451D-9529-AB00292321A3Q35537745-322C7E2C-58AD-4FC6-BD33-0CA689EC3DABQ35605044-2E982203-F0A5-4572-96A0-3A89797D5FDBQ35664290-E0906D25-CAD8-4DFC-8DDC-266375238D6FQ35816368-CF11A17A-EE12-49A7-80BC-189068B60459Q36017230-88DB8C03-CB7B-4382-AA4D-16E9D8E4011EQ36042320-96F32B9B-F485-4B6E-A84A-32270BC2C708Q36137001-AB965911-8218-44B5-9E41-5B68E04FFBDFQ36175569-AB1DBCB5-4547-4429-B348-7622B98BCF86Q36324489-B1AD7D39-F484-4E51-9C05-177D0BCAD6B8Q36382372-FD7B60CB-CFD9-4AD4-AEE2-7D0BC6A1A55E
P2860
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@ast
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@en
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@nl
type
label
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@ast
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@en
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@nl
prefLabel
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@ast
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@en
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@nl
P2093
P356
P1476
U.K. Controlled trial of intrapleural streptokinase for pleural infection.
@en
P2093
Andrew J Nunn
Christopher W H Davies
Donald J Lane
Emma L Hedley
Fergus V Gleeson
First Multicenter Intrapleural Sepsis Trial (MIST1) Group
Glyn L Rees
Janet H Darbyshire
Mark A Woodhead
Nicholas A Maskell
P304
P356
10.1056/NEJMOA042473
P407
P577
2005-03-01T00:00:00Z